Home » Topics » BioWorld Science

BioWorld Science
RSS

New AXL/Mer/c-Met/VEGFR-2 inhibitors discovered at Exelixis

Dec. 31, 2020

New phase I/II study explores use of TY-101 for solid tumors and lymphomas

Dec. 31, 2020

Lanzhou University synthesizes siRNAs targeting OLFML2A

Dec. 31, 2020

Ascendis files IND for TransCon TLR7/8 agonist

Dec. 31, 2020

FDA clears LyGenesis' IND for phase IIa study of cell therapy for end-stage liver disease

Dec. 31, 2020

Arcturus selects ARCT-032 as development candidate for cystic fibrosis

Dec. 31, 2020

Codiak reports initial phase I data on exoIL-12 for CTCL

Dec. 31, 2020

Altimmune initiates phase II trial of HepTcell for chronic hepatitis B

Dec. 31, 2020

Saroglitazar magnesium approved in India for NAFLD

Dec. 31, 2020

Sulanda approved in China for non-pancreatic NETs

Dec. 31, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...